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The mode of transmission of Helicobacter pylori
infection is poorly characterized. In northern California,
2,752 household members were tested for H. pylori infec-
tion in serum or stool at a baseline visit and 3 months later.
Among 1,752 person considered uninfected at baseline,
30 new infections (7 definite, 7 probable, and 16 possible)
occurred, for an annual incidence of 7% overall and 21%
in children <2 years of age. Exposure to an infected
household member with gastroenteritis was associated
with a 4.8-fold (95% confidence interval [CI] 1.4–17.1)
increased risk for definite or probable new infection, with
vomiting a greater risk factor (adjusted odds ratio [AOR]
6.3, CI 1.6–24.5) than diarrhea only (AOR 3.0, p = 0.65).
Of probable or definite new infections, 75% were attributa-
ble to exposure to an infected person with gastroenteritis.
Exposure to an H. pylori–infected person with gastroen-
teritis, particularly vomiting, markedly increased risk for
new infection.
H
elicobacter pylori infects at least 50% of the world’s
population. Infection occurs in early life (1,2).
Because acute infection invariably passes undetected,
however, the precise age of acquisition is unknown. In
industrialized countries, infection rates are declining rapid-
ly (1,3), but high rates of infection persist among disadvan-
taged and immigrant populations (4,5).
The mechanisms of H. pylori transmission are incom-
pletely characterized. Person-to-person transmission is
most commonly implicated with fecal/oral, oral/oral, or
gastric/oral pathways (6); each has supportive biologic as
well as epidemiologic evidence. Like many common
gastrointestinal infections, infection is associated with
conditions of crowding and poor hygiene (7,8) and with
intrafamilial clustering (9–12). The organism has been
recovered most reliably from vomitus and from stools dur-
ing rapid gastrointestinal transit (13). These findings raise
the hypothesis that gastroenteritis episodes provide the
opportunity for H. pylori transmission.
Household transmission of gastroenteritis is common in
the United States, particularly in homes with small chil-
dren (14). If H. pylori is transmitted person to person, one
might expect rates of new infection to be elevated after
exposure to persons with H. pylori–infected cases of gas-
troenteritis. To explore whether diarrhea or vomiting con-
tributes to disease transmission, we monitored northern
Californian households experiencing gastroenteritis for
new H. pylori infections and evaluated the contributions of
household H. pylori infection and gastroenteritis to new
infection. We were also interested in whether symptoms of
new infection could be identified.
Methods
Population and Study Design
The study population consisted of households that were
participating in the Stanford Infection and Family
Transmission study, initiated in 1999 to prospectively eval-
uate the association of H. pylori infection and household
gastroenteritis (14,15). The cohort, predominately Hispanic
immigrant families residing in South San Francisco Bay,
has a high seroprevalence of H. pylori infection (16,17).
From January 2000 to July 2004, a total of 3,846 persons
seen at 1 of 15 community (predominately low-
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both, were asked for permission to be contacted by a study
representative for a phone screening. Of 2,941 households
that could be contacted, 2,155 (73%) were eligible multi-
person households (within 50 miles of the research site,
within 12 days of gastroenteritis onset of index patients).
Of these, 852 (40%) declined interest, and 1,303 (60%)
were scheduled for a home visit. At the first home visit,
consenting household members were interviewed regard-
ing symptoms, onset, and duration of gastroenteritis with-
in the previous 21 days. Blood and stool samples were
collected for H. pylori testing. 
Stool samples were requested from children <2 years of
age and from others who refused phlebotomy.
Approximately 3 months later (range 12–20 weeks),
household members were reinterviewed, and a second
specimen was collected for H. pylori testing. Participation
was voluntary; small gifts (i.e., a mug, a tote bag, hand
antiseptic, a calendar) were offered as thanks for participa-
tion. The study was approved by the institutional review
boards of Stanford University, Santa Clara and San Mateo
Counties, and the state of California.
Laboratory Methods
H. pylori Serologic Testing
Anti–H.pylori immunoglobulin G (IgG) was quantified
by using an in-house ELISA(18), previously validated and
adapted for use in US, Latin American, and Asian popula-
tions (19–21). Optical density (OD) results were catego-
rized as negative (<85% of low positive standard),
borderline (85%–110% of low positive standard), or posi-
tive (>110% of low positive standard). In different series
of control samples with biopsy-confirmed infection, the
assay, which includes 6 different isolates (2 from Mexico),
is 91% sensitive and 98% specific for infection in adults
(15,18). For our study, an equivalent sensitivity and speci-
ficity were established for children >2 years of age by
using samples from controls with biopsy-confirmed infec-
tion from a separate study to establish a lower OD cut-off
(75% of adult control) (15). Serologic testing results are
considered unreliable in children <2 years of age (22).
Each serum sample was tested in triplicate for H. pylori
on 2 occasions, soon after it was received and later, when
it was paired with the second visit sample from the same
study participant. Between testing, samples were frozen at
−80°C. The paired serum results are presented here. High
reproducibility between first and second runs of the same
sample (mean coefficient of variation 18 ± 17) suggests
that the effect of freezing or storage was negligible. Titer
levels were derived from ODs by standard curve methods.
Aseroconversion was defined as a qualitative change from
negative to positive, negative to borderline, or borderline
to positive, if accompanied by >4-fold increase in H. pylori
titer from baseline. A seroreversion was defined as a qual-
itative change from positive to negative, accompanied by
>2-fold decrease in H. pylori titer.
To corroborate recent H. pylori infection (23), serum
samples from 22 IgG seroconverters and 22 randomly
sampled, persistently seronegative adults were tested for
H. pylori IgM antibody response in the laboratory of Dr.
Perez-Perez by using a mixed strain assay previously vali-
dated in ethnically diverse and pediatric populations
(9,24). Detection of an IgM antibody response at either
first or 12-week follow-up visit was considered a positive
test result.
H. pylori Stool Antigen
Stool antigen was tested with the Premier Platinum
HpSA enzyme immunoassay (Meridian, Cincinnati, OH,
USA). Stool samples collected at home visits were trans-
ported to the laboratory and stored at –20°C until
processed. Samples not available at the home visit were
expressed by overnight mail. In 1 metaanalysis, stool anti-
gen had a mean sensitivity and specificity of 91% and 93%,
respectively (25); however, accuracy may be lower in chil-
dren <6 years of age (26). In the present study population,
H. pylori was identified by PCR in 12 (46%) of 26 tran-
siently positive stool samples from toddlers (vs. 0% of 10
stool antigen–negative samples), a finding that was consis-
tent with the 50% sensitivity of PCR observed in H. pylori–
inoculated stools (27). A stool conversion was defined as a
qualitative change from negative to positive when the man-
ufacturer’s suggested cut-off values were used.
Testing Protocol
We requested stool and serum from all participants >2
years of age, although participants were included in the
study if they offered 1 or the other. For practical reasons
(i.e., stool samples are not typically available on demand
and are unpleasant to ship) most persons >2 years of age
(97%) provided only blood samples. Approximately 29%
of children <2 years of age provided only blood samples,
and 39% provided both blood and stool samples. The 13C
urea breath test was not considered because of costs and
the accuracy of the applied methods (22).
Definitions
Gastroenteritis
Gastroenteritis was defined as either 1) >3 loose or
watery stools per day in persons at least 2 years of age, or
>5 per day in children <2, or 2) any vomiting. Symptoms
lasting >14 days or reported symptoms due to potentially
noninfectious causes (poisoning, pregnancy, chemothera-
py) were excluded from the case definition (14,15).
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out diarrhea, or diarrhea alone. Only cases of gastroenteri-
tis identified at the baseline visit were included in the
present analysis.
New Infection
Given low expected rates of new infection and the role
of testing error (28,29), we developed criteria for definite,
probable, and possible infection on the basis of corrobora-
tive test results. A definite new infection was a seroconver-
sion with confirmatory stool or IgM result. Aprobable new
infection was a borderline seroconversion with confirmato-
ry stool or IgM or a stool conversion with confirmatory IgG
or IgM. Possible new infections met criteria for serologic or
stool conversion without confirmation. Since serum speci-
mens were not routinely obtained from children <2 years of
age, a single stool conversion was the only way of diagnos-
ing new infection in most of these children.
Persistent Negative/Persistent Positive
Apersistent negative infection had no positive or equiv-
ocal test results during observation. A persistent positive
infection had no negative or equivocal test results during
observation. Atransient infection was defined as a qualita-
tive seroreversion with >2-fold decrease in H. pylori titer
or a qualitative (positive to negative) stool reversion.
Study participants with equivocal (40 qualitative serocon-
versions with <4-fold increase in H. pylori titer and 32
qualitative seroreversions with <2-fold decrease in H.
pylori titer) or transient (7 serology and 28 stool) test
results were not considered for outcomes but were includ-
ed as baseline household exposures.
Household Exposure 
A person was considered exposed to gastroenteritis, H.
pylori infection, or H. pylori infection with gastroenteritis
if >1 other person in the home had 1 of these profiles at the
baseline visit. Household members who were not available
for second visit testing (499 or 15% of baseline partici-
pants) were counted as baseline exposures but could not be
considered for outcomes.
Statistical Analysis
Incidence of New Infection
We estimated the annual incidence of new infection and
95% confidence intervals (CIs) (30) for all ages and for
age categories 0–2, 2–17, and >18 years. The outcome was
the proportion of new infections in the age category, and
the denominator was the total number of study participants
in the age category who tested negative at baseline and
who completed the second visit testing. For comparison,
annualized rates of seroconversion and seroreversion are
also reported. The denominator for estimating serorever-
sions included all persons who tested positive at the first
visit and who completed second-visit testing.
Classification and Symptoms of New Infections
Classification of new infections (definite, probable, or
possible) is described. The χ2 test or Wilcoxon test for cat-
egorical and continuous measures, respectively, and logis-
tic regression for multivariable adjustment were used to
evaluate symptoms and other characteristics of new infec-
tions versus persistent negative results.
Incidence of New Infection by Household Exposure
We compared rates of new infection for study partici-
pants who resided with no known H. pylori–infected con-
tact, with >1 infected contact, and with >1 infected
contact who had gastroenteritis. The denominator for
these estimates was the number of study participants with-
in each exposure category who tested negative at baseline
and who completed second-visit testing. Household mem-
bers who were not available for second-visit testing or
who completed both visits with equivocal changes in titer
were counted as baseline exposures but could not be con-
sidered for outcomes.
Exposure to Gastroenteritis in an 
H. pylori–Infected Contact
Among study participants residing with >1  H.
pylori–infected contact, we estimated the odds (and 95%
CIs) of new infection, given exposure to infection with
versus without gastroenteritis, including symptoms of gas-
troenteritis (vomiting versus diarrhea only). To minimize
misclassification, the outcome for this analysis was
restricted to definite and probable new infections, and the
reference group with persistent negative results who had
been exposed to H. pylori infection at baseline. A random
intercept logistic regression model (Proc Glimmix.,
SAS/Stat, 9.2 ed., SAS Institute, Cary, NC, USA) was used
to model household clusters and to adjust for age, sleeping
density, and proportion of household members completing
both visits, each modeled as a continuous variable. We also
calculated the attributable risk (30) of new infection asso-
ciated with exposure to H. pylori infection and to exposure
to H. pylori infection with gastroenteritis. As a secondary
analysis, we assessed risk factors for all new infections,
including possible new infections.
Results
From January 2000 to June 2004, a total of 1,186
households were enrolled. These 1,186 households includ-
ed 6,620 participants who participated in the first gastroen-
teritis interview, and 4,334 (65%) who also gave
specimens. Households were predominately Spanish-
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ters (72%) of households had >1 H. pylori–infected house-
hold participant at the first visit.
Of enrolled households, 277 (23%), including 108 that
dropped out and 169 that could not be located, did not
complete the second visit (Table 1). Although the 909
households that did complete the study appeared some-
what smaller (median 5 vs. 6 household members, p = 0.06
Wilcoxon), the proportion of large households (>8 con-
tacts) was not significantly different (20% vs. 19%).
Conversely, enrollments (median 3 per household) were
similar, although completing households were somewhat
more likely to enroll more than the minimum of 2 partici-
pants (72% vs. 64%). Households that did not complete the
study were also more likely to have been referred through
an emergency department (21% vs. 15%, p = 0.02) but
were similar in number of children enrolled, primary
household language, sleeping density, educational attain-
ment, and prevalence of H. pylori infection.
Incidence of New Infection 
The 909 households that completed the second visit had
3,380 household participants; 2,881 (85%) completed both
specimen collections. Of these, 129 (4.4%) were children
<2 years of age who contributed only serum and were
excluded from analysis because of lack of validation of our
ELISA results in early childhood. Thus, a total of 2,752
household members, 2,372 (86%) with serologic results
and 380 (14%) with stool or stool and serologic results,
completed second-visit testing. Of these, 1,752 (64%) test-
ed negative at baseline. Over a median 13 (±2) weeks of
follow-up, 30 (1.7%) of these met the definition of a new
infection, for an overall annualized incidence of 6.8%
(95% CI 4.6%–9.8%). By serology, corresponding annual-
ized seroconversion and seroreversion rates were 3.7% and
3.1%, respectively. Half of all new infections occurred in
children <2 years of age, for an annualized rate of 20.9%
(95% CI 11.8%–33.9%) in this age group versus 5.3%
(2.4%–9.6%) in persons 2–17 years, and 3% (0.9%–6.5%)
in persons >18 years.
Classification and Symptoms of New Infections
Among the 30 new infections, 7 met criteria for a defi-
nite new infection, 7 for a probable new infection, and 16
for a possible new infection (Table 2). The 7 definite IgG
seroconversions included 4 corroborated with IgM and 3
seroconversions corroborated with change in stool antigen.
Of the 7 probable new infections, 2 stool conversions (both
in children <2 years of age) were corroborated with IgM,
4 borderline seroconversions were corroborated with IgM,
and 1 borderline seroconversion was corroborated with
stool antigen. Overall, 10 (45%) of the 22 stool or serocon-
versions tested had a positive IgM response at the first or
second visit of the study participant, compared to 4 (18%)
of 22 randomly selected persistent seronegatives (p =
0.05). The 16 possible new infections included 12 stool
conversions, all in children <2 years, and 4 uncorroborat-
ed borderline seroconversions.
Overall, 175 children <2 years had serologic and stool
results for each visit. Among 350 stool serum pairs, 335
(96%) were concordant, including 3 of 10 new infections
and 2 transient infections. Of the 15 discordant results, 7
were stool conversions discordant at the study participant’s
second visit, 6 were stool reversions discordant at the par-
ticipant’s first visit (4 of these were corroborated by PCR
in another study [27], and 2 were persistently stool positive
or negative with discordant serology at 1 or both study par-
ticipant visits).
Compared with 1,722 persistently negative results, the
30 new infections were in significantly younger study par-
ticipants (median age 2 vs. 11 years, p<0.001) but of sim-
ilar gender (40% male vs. 43% male, p = 0.78). When
results were adjusted for age, new infections were some-
what more likely than persistently negative results to be in
persons with gastroenteritis (adjusted odds ratio [AOR]
2.5, CI 0.97–6.6, p = 0.06), and the 14 definite or probable
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CI 1.1–22.4, p = 0.04). No specific gastroenteritis symp-
toms for new infection were identifiable.
Incidence of New Infection by Household Exposure 
Seven (7) new infections occurred in homes with no
known  H. pylori–infected participants (Figure) and 23
(77%) in homes with >1 infected contact, for rates of new
infection of 1.1% and 2.1%, respectively (p = 0.10). Two
households with exposure to an H. pylori–infected contact
manifested 2 new infections (Table 2). Conversely, 1,319
(75%) study participants were exposed to gastroenteritis in
another household member; new infection developed in 16
(1.2%), compared with 14 (3.2%) of 433 study participants
not exposed (p = 0.005). However, new infection devel-
oped in 10 (2.9%) of 350 study participants exposed to an
H. pylori–infected contact with gastroenteritis, compared
with 6 (0.6%) of 969 of study participants exposed to gas-
troenteritis in an uninfected contact (p = 0.001).
Exposure to Gastroenteritis in an 
H. pylori–Infected Contact
Of 14 definite or probable new infections, 11 (79%)
occurred in homes with >1  H. pylori–infected contact
(Table 2). When adjusted for age, sleeping density, and
proportion of household contacts completing both visits,
exposure to an H. pylori–infected person with gastroenteri-
tis increased risk for definite or probable new infection
4.8-fold (95% CI 1.4–17.1, p = 0.01) compared with expo-
sure to infected persons without gastroenteritis. Exposure
to an H. pylori–infected person with vomiting was a signif-
icantly stronger risk factor for new infection (p = 0.03)
than exposure to an H. pylori–infected person with gas-
troenteritis but no vomiting (Table 3). The proportions of
definite or probable new infections attributable to expo-
sure to an H. pylori–infected person without and with gas-
troenteritis were 55% and 75%, respectively. Including
possible new infections in the analysis decreased the
magnitude of the associations with gastroenteritis (Table 3)
Helicobacter pylori Infection and Gastroenteritis
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vomiting remained a significant risk factor.
Discussion
In this prospective study of H. pylori infection and
household gastroenteritis within a US immigrant popula-
tion, we estimated an annualized H. pylori incidence rate
of 7%, including 21% among children <2 years of age.
Exposure to H. pylori–infected persons with gastroenteri-
tis, particularly with vomiting, increased risk for new
infection, and three quarters of definite or probable new
infections were attributable to exposure to H. pylori infec-
tion with gastroenteritis. These findings indicate that in US
immigrant homes, H. pylori transmission occurs in young
children during household episodes of gastroenteritis.
Exposure to an infected household member with vom-
iting was associated with a 6-fold greater risk for new
infection, whereas exposure to diarrhea elevated, but not
significantly, the risk for new infection. These findings are
consistent with prior research that shows that H. pylori is
recovered reliably from vomitus (up to 30,000 CFU/mL)
and can also can be grown from aerosolized vomitus col-
lected at short distances (<1.2 m) (13). Epidemiologic
investigations also implicate vomitus as an effective vehi-
cle for gastro-oral transmission (31,32). Although found in
diarrheal stools (13), H. pylori is not reliably grown from
normal stools (33). The association between H. pylori and
gastroenteritis is thus similar to that of other enteric
pathogens that can be transmitted by vomitus or
aerosolized vomitus or by the fecal-oral route (34,35).
Although we cannot exclude other mechanisms of trans-
mission in these homes, exposure to vomitus in an infect-
ed contact explained >50% of all new infections and >70%
of definite and probable new infections.
Among our interests was identifying symptoms of new
H. pylori infection. In experimental exposure, acute infec-
tion causes mild to moderate epigastric discomfort or dys-
pepsia in most study participants within 2 weeks, but
symptoms are unlikely to be clinically detected (36).
Although H. pylori–specific IgM antibodies may appear
within 4 weeks, the frequency of this response is variable,
particularly in children and when, as here, the time of
infection is unknown (37). We did not observe a pro-
nounced difference in the frequency or distribution of
symptoms associated with new infection, although vomit-
ing tended to be more frequent among persons with defi-
nite or probable new infections. Although the relatively
small numbers of new cases may have limited the power of
this analysis, no symptom complex was identified that
would permit differentiation of acute H. pylori infection
from other enteric processes. Because we did not establish
the specific etiologic agent of gastroenteritis episodes, fur-
ther studies are needed to more fully address this question.
Half of new infections were in children <2 years of
age, and 2 of 3 were identified by a single unconfirmed
stool conversion. Although H. pylori infection is acquired
in early childhood, age of acquisition has been difficult to
establish because of known limitations of existing nonin-
vasive tests in very young children. In a Bogalusa,
Louisiana, birth cohort, for example, the highest serocon-
version rate (2%) was seen in children 4–5 years of age
(2). Although stool antigen and urea breath tests are con-
sidered more accurate (22), studies in very young children
are still limited. When the urea breath test was used, an
annualized conversion rate more similar to ours (20%)
was observed in the US–Mexican binational Pasitos
cohort of children followed up from birth to 2 years (38).
If, as suggested by this and other studies (24,27,39,40),
acquisition with transient infection in early life often pre-
cedes persistent infection, rates of acquisition might be
elevated when exposure to gastroenteritis is frequent.
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Figure. Rates of new Helicobacter pylori infection overall, without
exposure to an infected contact (none); to >1 infected contact with-
out gastroenteritis (Without GE), or to >1 infected contact who had
gastroenteritis (With GE). Bar annotations denote number of new
infections and number at risk. Definite/probable/possible, see text
for classification of new infections.While the extent to which testing error confounds
pediatric incidence studies is not clear, rates of acquisition
among children in homes at high risk may nonetheless be
meaningful measures of transmission risk.
Given the possibility of error in serologic and stool
antigen tests, we cannot exclude the possibility that 30 new
infections would occur by chance (28,29). Among those
tested by serology, for example, the reversion rate was
roughly equivalent to the seroconversion rate, which sug-
gests that false-positive tests were occurring equally in the
first and second screening. Because the predictive value of
a single test in a low prevalence population may be <50%,
we used a corroborative testing algorithm and restricted
our risk factor analysis to those who had a confirmatory
test of conversion. Despite the small number of cases, an
association with exposure to H. pylori and gastroenteritis
was highly significant. Although CIs were wide, the fact
that risk estimates were uniformly strengthened in the sub-
set of persons with corroborative test results lends validity
to this approach, as well as underscoring the desirability of
using a second test more routinely in incidence studies. 
Although households that completed the study were
largely representative of enrolled households, a substan-
tial proportion of contacts in homes that completed the
study either declined to participate (35%) or did not com-
plete the second visit (15%). While rates of baseline H.
pylori infection were virtually identical in those complet-
ing 1 or 2 visits, and participation rates were largely sim-
ilar across household exposure profiles, we cannot
exclude the possibility that the missing data were mean-
ingful. If misclassification of gastroenteritis did occur,
linkage with outcome is unlikely, since H. pylori infection
status is not typically known. For these reasons, we
assume that misclassification was random, minimizing the
magnitude of true associations.
In summary, this study corroborates the conclusion that
gastroenteritis, particularly with vomiting, in an H.
pylori–infected person is a primary cause of transmission
of H. pylori in humans. Despite some study limitations, the
strength of association observed suggests an important
milieu for future work to elucidate transmission pathways
in low prevalence countries. As with other enteric infec-
tions such as hepatitis A, shigellosis, and cholera, H. pylori
infection rates have decreased dramatically with improve-
ments in sanitary infrastructure and household hygienic
practices. Despite these trends, acquisition and infection
are likely to remain prevalent in households with preexist-
ing H. pylori infection, crowded living conditions, and fre-
quent gastroenteritis.
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